Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App




Genome Sequencing Evaluated in Children with Unexplained Medical Complexity

By LabMedica International staff writers
Posted on 08 Oct 2020
Children with medical complexity (CMC) have at least one chronic condition, depend on a technological tool like a ventilator or require intravenous nutrition or drugs, are under the care of multiple subspecialists, and have substantial healthcare use.

Collectively, rare genetic conditions are an important cause of severe pediatric morbidity and mortality. A genetic diagnosis can inform prognosis, anticipatory care, management, and reproductive planning. Rapid genome sequencing as a first-tier test in neonatal and pediatric intensive care units has been associated with a high diagnostic yield and potential health care cost savings.

A team of medical geneticists from The Hospital for Sick Children (Toronto, ON, Canada) and some colleagues recruited families taking part in a structured complex care program. Following medical record review, 143 families met eligibility criteria, and 54 of them were interested and met additional criteria. Patients were eligible if they were thought to have an underlying genetic condition that had not been identified through conventional genetic testing. In all, 138 individuals from 49 families underwent genome sequencing, including 40 parent-child trios.

Genome sequencing was performed using established methods, with high-quality DNA extracted from whole blood. In brief, library preparation was performed from 500 ng of DNA using the TruSeq Nano DNA Library Preparation Kit (Illumina Inc, San Diego, CA, USA) omitting the polymerase chain reaction amplification step, followed by sequencing on an Illumina HiSeq X platform. Single-nucleotide variations (SNVs) and indels were detected using Genome Analysis Toolkit, version 3.4-46 or version 3.7 (Broad Institute, Cambridge, MA, USA).

Genome sequencing detected all genomic variation previously identified by conventional genetic testing. A total of 15 probands (30.6%) received a new primary molecular genetic diagnosis after genome sequencing. Three individuals had novel diseases and an additional nine had either ultra-rare genetic conditions or rare genetic conditions with atypical features. At least 11 families received diagnostic information that had clinical management implications beyond genetic and reproductive counseling. One patient, for instance, had a maternally inherited single-exon duplication in the KDM6A gene on the X chromosome that causes Kabuki syndrome, which was not detected by chromosomal microarray analysis, exome sequencing, or a multiplex ligation-dependent probe amplification test of the gene.

The authors concluded that genome sequencing has high analytical and clinical validity and can result in new diagnoses in CMC even in the setting of extensive prior investigations. This clinical population may be enriched for ultra-rare and novel genetic disorders. Genome sequencing is a potentially first-tier genetic test for CMC. The study was published on September 22, 2020 in the journal JAMA Network Open.




Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Coagulation Analyzer
CS-2400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.